相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 CSF1/M-CSF 抗体 (拉妥珠单抗),生物类似药,科研用途 [ CAS: 1831128-32-5]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Humanized
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
CSF1/M-CSF
- 抗体名:
CSF1/M-CSF
- 规格:
1mg
BioSIM 抗人 CSF1/M-CSF 抗体 (拉妥珠单抗) 生物类似药
产品概述
InvivoCrown提供的BioSIM抗人CSF1/M-CSF抗体是一种高品质的拉妥珠单抗生物类似药,专为科研用途设计。该产品CAS号为1831128-32-5,货号SIM0853-1mg,是一种人源化二抗,可特异性识别人类CSF1/M-CSF蛋白。
产品特点
- 先进生产工艺:该重组生物类似抗体在无动物成分的设施中生产,确保产品的一致性和纯度
- 无蛋白细胞培养:采用体外的无蛋白细胞培养技术,避免了动物源性成分的污染
- 多步纯化工艺:经过包括Protein A或G色谱工艺在内的多步骤纯化过程,确保高纯度
- 人源化设计:来源于人源化宿主,具有更好的免疫相容性
应用领域
该抗体广泛应用于多种实验技术和研究领域,包括:
- 实验技术:ELISA、FACS、功能性实验(Functional assay)、体内研究(Research in vivo)
- 研究方向:三阴性乳腺癌、乳腺癌、骨转移癌等相关癌症研究
产品参数
| 产品名称 | BioSIM anti-Human CSF1/M-CSF Antibody (Lacnotuzumab Biosimilar), Research Grade |
| 中文名称 | BioSIM 抗人 CSF1/M-CSF 抗体 (拉妥珠单抗),生物类似药,科研用途 |
| CAS号 | 1831128-32-5 |
| 产品类型 | 二抗 |
| 供应商 | InvivoCrown |
| 产品货号 | SIM0853-1mg |
| 产品规格 | 1mg |
| 来源宿主 | Humanized |
| 反应性 | Human |
保存与运输
为确保产品的稳定性和活性,请按照以下条件储存:
- 短期储存:对于1-2周内的使用需求,请于4°C条件下保存
- 中期储存:最长12个月的储存,请于-20°C条件下保存
- 长期储存:建议在-80°C条件下保存,以获得最佳的长期稳定性
- 重要提醒:请避免反复冻融,以防止产品活性下降
注意事项
该产品仅限科研用途,不可用于诊断或治疗。关于免疫原的详细信息,请参考产品说明书。使用时请遵循实验室安全操作规范,并穿戴适当的个人防护装备。
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM anti-human CSF1/M-CSF Antibody (Lacnotuzumab Biosimilar)
Product Overview
The BioSIM anti-human CSF1/M-CSF antibody provided by InvivoCrown is a high-quality Lacnotuzumab biosimilar designed for research purposes. This product has CAS number 1831128-32-5, catalog number SIM0853-1mg, and is a humanized secondary antibody that specifically recognizes human CSF1/M-CSF protein.
Product Features
- Advanced Production Process: The recombinant biosimilar antibody is produced in animal-component-free facilities to ensure product consistency and purity
- Protein-Free Cell Culture: Utilizes in vitro protein-free cell culture technology to avoid contamination from animal-derived components
- Multi-step Purification Process: Undergoes multi-step purification including Protein A or G chromatography to ensure high purity
- Humanized Design: Derived from humanized host with better immunocompatibility
Application Areas
This antibody is widely used in various experimental techniques and research areas, including:
- Experimental Techniques: ELISA, FACS, Functional assay, Research in vivo
- Research Areas: Triple-negative breast cancer, breast cancer, bone metastasis and related cancer research
Product Parameters
| Product Name | BioSIM anti-Human CSF1/M-CSF Antibody (Lacnotuzumab Biosimilar), Research Grade |
| Chinese Name | BioSIM anti-human CSF1/M-CSF Antibody (Lacnotuzumab Biosimilar), for research use |
| CAS Number | 1831128-32-5 |
| Product Type | Secondary antibody |
| Supplier | InvivoCrown |
| Catalog Number | SIM0853-1mg |
| Product Specification | 1mg |
| Source Host | Humanized |
| Reactivity | Human |
Storage and Transportation
To ensure product stability and activity, please store under the following conditions:
- Short-term Storage: For use within 1-2 weeks, store at 4°C
- Medium-term Storage: For storage up to 12 months, store at -20°C
- Long-term Storage: Recommended to store at -80°C for optimal long-term stability
- Important Reminder: Avoid repeated freeze-thaw cycles to prevent loss of product activity
Precautions
This product is for research purposes only and not for diagnostic or therapeutic use. For detailed information about immunogenicity, please refer to the product manual. Follow laboratory safety protocols and wear appropriate personal protective equipment when using this product.
Note: The information above may be subject to change due to product optimization and upgrades. For specific information, please consult Yakeyin Company.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料






